LIFLX
Price
$15.38
Change
-$0.07 (-0.45%)
Updated
Aug 15 closing price
Net Assets
54.44M
VVIAX
Price
$70.31
Change
-$0.09 (-0.13%)
Updated
Aug 15 closing price
Net Assets
195.81B
Interact to see
Advertisement

LIFLX vs VVIAX

Header iconLIFLX vs VVIAX Comparison
Open Charts LIFLX vs VVIAXBanner chart's image
Lord Abbett Focused Large Cap Value I
Price$15.38
Change-$0.07 (-0.45%)
VolumeN/A
Net Assets54.44M
Vanguard Value Index Adm
Price$70.31
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets195.81B
LIFLX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LIFLX vs. VVIAX commentary
Aug 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIFLX is a StrongBuy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 196B vs. LIFLX (54.4M). VVIAX pays higher dividends than LIFLX: VVIAX (2.18) vs LIFLX (0.79). LIFLX was incepted earlier than VVIAX: LIFLX (6 years) vs VVIAX (25 years). LIFLX (1.39) is less costly to investors than VVIAX (0.05). LIFLX is a more actively managed with annual turnover of: 58.00 vs. VVIAX (9.00). VVIAX has a lower initial minimum investment than LIFLX: VVIAX (3000) vs LIFLX (1000000). LIFLX annual gain was more profitable for investors over the last year : 15.73 vs. VVIAX (7.91). VVIAX return over 5 years is better than : 68.54 vs. LIFLX (14.04).
LIFLXVVIAXLIFLX / VVIAX
Total Expense Ratio0.710.051,420%
Annual Report Gross Expense Ratio1.390.052,780%
Fund Existence6 years25 years-
Gain YTD12.5926.517193%
Front LoadN/AN/A-
Min. Initial Investment1000000300033,333%
Min. Initial Investment IRAN/AN/A-
Net Assets54.4M196B0%
Annual Yield % from dividends0.792.1836%
Returns for 1 year15.737.91199%
Returns for 3 years8.3725.9332%
Returns for 5 years14.0468.5420%
Returns for 10 yearsN/A114.61-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
EPIX1.930.01
+0.52%
ESSA Pharma
KTTA0.70N/A
N/A
Pasithea Therapeutics Corp
MANH214.79-0.41
-0.19%
Manhattan Associates
NRIM86.31-1.03
-1.18%
Northrim BanCorp
NBTB42.13-0.95
-2.21%
NBT Bancorp